Description

GLOW — BPC-157 + TB-500 + GHK-Cu Research Peptide Blend

Lyophilized Powder | Third-Party Tested | USA-Manufactured

In Stock | Free Shipping on Orders Over $150

---

Product Specifications

• Peptide Name: GLOW (BPC-157 + TB-500 + GHK-Cu)
• Composition: BPC-157 (10mg) / TB-500 (10mg) / GHK-Cu (70mg) | Total: 90mg
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder (combined vial)
• Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
• Shelf Life: Up to 12 months when stored sealed and dry

Compound	Sequence / Description	Molecular Formula	Molecular Weight	CAS Number
GHK-Cu	Gly-His-Lys copper(II) complex	C14H24N6O4Cu	401.93 g/mol	49557-75-7
TB-500	Synthetic peptide fragment of thymosin beta-4	C212H350N56O78S	4963.4 g/mol	77591-33-4
BPC-157	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val	C62H98N16O22	1419.5 g/mol	137525-51-0

 

---

Compound Overview

GLOW (BPC-157 + TB-500 + GHK-Cu) is a combined-vial peptide formulation composed of three distinct research peptide components: BPC-157, a short linear peptide sequence; TB-500, a synthetic peptide corresponding to a thymosin beta fragment; and GHK-Cu, a copper-binding tripeptide complex. Structurally, this formulation represents a multi-component peptide system containing both peptide fragments and a peptide–metal coordination complex used in experimental peptide characterization workflows.

In laboratory research contexts, multi-peptide combination vials such as GLOW are evaluated for component identity confirmation, stability profiling, and analytical separation of individual constituents using chromatographic and mass spectrometry workflows. Each component peptide class is described in experimental literature within controlled in vitro and preclinical animal model systems. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for GLOW (BPC-157 + TB-500 + GHK-Cu) as a research compound.

---

Published Preclinical Research

Published literature describes BPC-157, thymosin beta–derived peptide fragments, and copper-binding tripeptide complexes as defined research compounds investigated within controlled experimental systems.

• Structural characterization of multi-component peptide formulations using analytical identity workflows
• Peptide stability and degradation profiling for short synthetic peptide sequences in biological matrices
• Comparative evaluation of peptide fragments and peptide–metal complexes in controlled experimental models
• Analytical method development for multi-analyte peptide formulation testing in laboratory environments

All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for GLOW (BPC-157 + TB-500 + GHK-Cu).

---

Research Applications

• Multi-component peptide identity confirmation using LC-MS workflows
• Method development for separating and quantifying blended peptide components
• Peptide stability and degradation profiling under controlled conditions
• Comparative analytical evaluation of peptide fragments and peptide–metal complexes
• Preclinical peptide research using validated in vitro and animal model systems

---

Physical Specifications

• Vial Size: 3 mL sterile vial
• Fill: 10mg BPC-157 / 10mg TB-500 / 70mg GHK-Cu (90mg total)
• Appearance: Light blue lyophilized powder
• Reconstitution Volume: Researcher-determined under validated laboratory protocols
• Post-Reconstitution Storage: 2–8°C, use within 30 days
• Solubility: Water-based laboratory solvents

---

Individual Compounds Available

Each component in the GLOW blend is also available as a standalone research peptide:

BPC-157 (10mg)

• BPC-157 is a synthetic pentadecapeptide available as a single-compound vial for researchers requiring isolated peptide characterization without additional blend components.

TB-500 (10mg)

• TB-500 is a synthetic fragment of thymosin beta-4 available as a standalone research peptide for single-analyte laboratory workflows.

GHK-Cu (50mg)

• GHK-Cu is a copper-binding tripeptide complex available individually for researchers focused on peptide–metal coordination studies.

---

Compare to Related Compounds

BPC-157 + TB-500 (10mg/10mg)

• GLOW is a three-component formulation containing BPC-157, TB-500, and GHK-Cu, whereas BPC-157 + TB-500 is a two-peptide blend without a peptide–metal complex component.
• Multi-component formulations are differentiated in laboratory workflows by component count, analytical separation requirements, and multi-analyte identity confirmation methods.

KLOW (GHK-Cu + KPV + BPC-157 + TB-500)

• KLOW is a four-component formulation that adds KPV to the GLOW base of GHK-Cu, BPC-157, and TB-500, expanding the analytical scope to include antimicrobial peptide characterization.
• Researchers comparing GLOW and KLOW evaluate the contribution of KPV as an additional analyte in multi-peptide stability and interaction studies.

LL-37

• GLOW is a multi-component formulation containing two peptide fragments and one peptide–metal complex, whereas LL-37 is a single long-chain antimicrobial peptide consisting of 37 amino acids.
• These compounds differ in sequence length, structural classification, and analytical characterization requirements in laboratory peptide workflows.

Cagrilintide

• GLOW is a blended multi-peptide research formulation, whereas Cagrilintide is a single long-acting amylin analog peptide with distinct receptor classification and molecular architecture.
• Analytical differentiation focuses on multi-analyte separation and peptide–metal coordination verification versus single-entity peptide hormone characterization.

---

Handling & Storage

Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.

Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.

Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.

---

Certificate of Analysis & Third-Party Testing

Every batch of BioEdge GLOW (BPC-157 + TB-500 + GHK-Cu) undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.

Identity Confirmation	Mass Spectrometry (MS)
Purity Assessment	High-Performance Liquid Chromatography (HPLC)
Minimum Purity Acceptance	≥99%
Heavy Metals	ICP-MS panel
Sterility	USP <71> Sterility Testing
COA Format	Batch-specific test results, downloadable on product page

To view testing results, scroll to the 3rd Party Testing section located below the product image.

---

Why Researchers Choose BioEdge for GLOW (BPC-157 + TB-500 + GHK-Cu)

Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of GLOW (BPC-157 + TB-500 + GHK-Cu) ships with a Certificate of Analysis from an independent third-party laboratory. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.

USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.

No filler compounds. BioEdge GLOW (BPC-157 + TB-500 + GHK-Cu) is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.

Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.

---

Frequently Asked Questions

---

Published References

1. Sikiric P, et al. “Pentadecapeptide BPC 157 and the Central Nervous System.” NeuroRegulation. 2022;9(1):57-68. Link

2. Jaric S, et al. “BPC 157 and its effects in gastrointestinal, vascular, and nervous system contexts.” Current Neuropharmacology. 2016;14(8):723-731. Link

3. Li F, et al. “Thymosin Beta-4 and TB-500 research: Investigations in tissue dynamics and cellular responses.” Peptide Science Journal. 2024;110(2):e24412. Link

4. Liu Y, et al. “Hanacure review of glutathione and peptide interactions in cellular pathways.” International Journal of Molecular Sciences. 2018;19(7):1987. Link

---

RESEARCH USE ONLY Disclaimer

RESEARCH USE ONLY. GLOW (BPC-157 + TB-500 + GHK-Cu) is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.